市場調査レポート

商品コード

1179614

細胞株・膜の市場：製品別、供給元別、タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cell Line and Membrane Market By Products, By Source, By Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年09月01日 | 発行: Allied Market Research

| ページ情報: 英文 346 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,840 603,417円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 6,090 956,982円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,500 1,649,970円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細胞株・膜市場は、2021年に45億3,304万米ドルと評価され、2031年には105億7,456万米ドルに達し、2022年から2031年にかけてCAGR8.8%を記録すると予測されています。

細胞株は、与えられた適切な新鮮培地とスペースで無限に増殖する恒久的に確立した細胞培養物で、初代細胞の代わりに生体プロセスの調査に頻繁に使用されています。トランスフェクション、選択、単一細胞クローニングはすべて細胞株作製のプロセスの一部です。さまざまな種類の細胞が、さまざまな細胞株を作るために使われます。細胞株は、制御された環境で、細胞の構造、生理学、および遺伝的構成を徐々に変化させることができます。.細胞株は単一細胞に由来し、融合タンパク質、モノクローナル抗体、ワクチンなどの製造に使用されます。

細胞株は科学研究に革命をもたらし、ワクチン製造、薬物代謝・細胞毒性試験、抗体製造、遺伝子機能研究、人工組織（人工皮膚）の生成、生体化合物（治療用タンパク質）の合成などに広く利用されています。

市場成長の主な要因は、がんや慢性疾患の増加、老年人口の増加、ワクチン生産数の増加です。また、新薬開発活動の活発化、細胞株生産における哺乳類細胞の利用拡大、発現ベクター設計における技術的進歩の急増も、市場の成長を後押しする重要な要因となっています。例えば、国際がん研究機関によると、2020年にアジアで新たに診断されるがん患者は950万3710人です。

しかし、厳しい規制の枠組みと、安定した系統の開発に時間がかかることが相まって、市場成長の妨げとなっています。逆に、新興国や低所得国におけるヘルスケア市場の勃興、パンデミックや伝染病のリスクの増加は、予測期間中に市場成長のための有利な機会を提供すると予想されます。

概要
- 市場規模および予測
培地と試薬
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- 培地・試薬細胞株・膜の市場：タイプ別
  - 血清の市場規模・予測：地域別
  - 培地の市場規模・予測：地域別
  - 試薬の市場規模・予測：地域別
機器類
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- 細胞株・膜装置の市場：タイプ別
  - バイオセーフティキャビネットの市場規模・予測：地域別
  - セルカウンター、バイアビリティシステムの市場規模・予測：地域別
  - インキュベーターの市場規模・予測：地域別
  - 遠心分離機の市場規模・予測：地域別
  - バイオリアクター市場規模推移・予測：地域別
  - 保管装置の市場規模・予測：地域別
  - その他の市場規模・予測：地域別
付属品・消耗品
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章細胞株・膜市場：供給元別

概要
- 市場規模および予測
非哺乳類セルライン
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- 非哺乳類細胞株細胞株・膜の市場：タイプ別
  - 昆虫の市場規模・予測：地域別
  - 両生類市場規模・予測：地域別
哺乳類細胞株
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章細胞株・膜市場：タイプ別

概要
- 市場規模および予測
リコンビナントセルライン
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
プライマリーセルライン
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ハイブリドーマ
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
連続細胞株
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章細胞株・膜市場：エンドユーザー別

概要
- 市場規模・予測
バイオテクノロジー、製薬業界
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
学術・研究機関
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第8章細胞株・膜市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米の市場規模・予測：製品別
  - 北米の培地・試薬細胞株・膜の市場：タイプ別
  - 北米のセルラインとメンブレンの市場：タイプ別
- 北米の市場規模・予測：供給元別
  - 北米の非哺乳類細胞株細胞株・膜市場：タイプ別
- 北米の市場規模・予測：タイプ別
- 北米市場の規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：製品別
  - 欧州の培地・試薬セルライン・膜市場：タイプ別
  - 欧州のセルラインとメンブレンの市場：タイプ別
- 欧州の市場規模・予測：供給元別
  - 欧州の非哺乳類細胞株細胞株・膜市場：タイプ別
- 欧州市場規模・予測：タイプ別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：製品別
  - アジア太平洋地域の細胞培養用培地と試薬の市場：タイプ別
  - アジア太平洋地域のセルラインとメンブレンの市場：タイプ別
- アジア太平洋地域の市場規模・予測：供給元別
  - アジア太平洋地域の非哺乳類細胞株細胞株と膜の市場：タイプ別
- アジア太平洋地域の市場規模・予測：タイプ別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：製品別
  - LAMEAの培地・試薬セルライン・メンブレン市場：タイプ別
  - LAMEAの細胞培養装置と膜の市場：タイプ別
- LAMEAの細胞株と膜の市場規模・予測：供給元別
  - LAMEA非哺乳類細胞株細胞株・膜市場：タイプ別
- LAMEAの市場規模・予測：タイプ別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - LAMEAの残りの地域

第9章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第10章企業プロファイル

Advanced Instruments LLC
AGC Biologics
Cytiva Lifesciences
Sartorius
Cellgenix Gmbh
Premas Biotech
Selexis SA
Samsung Biologics
Lonza
Thermofisher Scientific Inc
PromoCell
ProBioGen

図表

LIST OF TABLES

TABLE 1. GLOBAL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 2. CELL LINE AND MEMBRANE MARKET, FOR MEDIA AND REAGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CELL LINE AND MEMBRANE MARKET FOR MEDIA AND REAGENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. CELL LINE AND MEMBRANE MARKET, FOR SERUM, BY REGION, 2021-2031 ($MILLION)
TABLE 6. CELL LINE AND MEMBRANE MARKET, FOR MEDIA, BY REGION, 2021-2031 ($MILLION)
TABLE 7. CELL LINE AND MEMBRANE MARKET, FOR REAGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 8. CELL LINE AND MEMBRANE MARKET, FOR EQUIPMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. CELL LINE AND MEMBRANE MARKET FOR EQUIPMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 11. CELL LINE AND MEMBRANE MARKET, FOR BIOSAFETY CABINETS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CELL LINE AND MEMBRANE MARKET, FOR CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. CELL LINE AND MEMBRANE MARKET, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CELL LINE AND MEMBRANE MARKET, FOR CENTRIFUGES, BY REGION, 2021-2031 ($MILLION)
TABLE 15. CELL LINE AND MEMBRANE MARKET, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. CELL LINE AND MEMBRANE MARKET, FOR STORAGE EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 17. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. CELL LINE AND MEMBRANE MARKET, FOR ACCESSORIES AND CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. CELL LINE AND MEMBRANE MARKET FOR ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. GLOBAL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 21. CELL LINE AND MEMBRANE MARKET, FOR NON MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
TABLE 22. CELL LINE AND MEMBRANE MARKET FOR NON MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GLOBAL NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 24. CELL LINE AND MEMBRANE MARKET, FOR INSECTS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. CELL LINE AND MEMBRANE MARKET, FOR AMPHIBIANS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. CELL LINE AND MEMBRANE MARKET, FOR MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
TABLE 27. CELL LINE AND MEMBRANE MARKET FOR MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. GLOBAL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. CELL LINE AND MEMBRANE MARKET, FOR RECOMBINANT CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 30. CELL LINE AND MEMBRANE MARKET FOR RECOMBINANT CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. CELL LINE AND MEMBRANE MARKET, FOR PRIMARY CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 32. CELL LINE AND MEMBRANE MARKET FOR PRIMARY CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. CELL LINE AND MEMBRANE MARKET, FOR HYBRIDOMAS, BY REGION, 2021-2031 ($MILLION)
TABLE 34. CELL LINE AND MEMBRANE MARKET FOR HYBRIDOMAS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. CELL LINE AND MEMBRANE MARKET, FOR CONTINUOUS CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 36. CELL LINE AND MEMBRANE MARKET FOR CONTINUOUS CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. GLOBAL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. CELL LINE AND MEMBRANE MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 ($MILLION)
TABLE 39. CELL LINE AND MEMBRANE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. CELL LINE AND MEMBRANE MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 41. CELL LINE AND MEMBRANE MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 43. CELL LINE AND MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 44. CELL LINE AND MEMBRANE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. U.S. CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 54. U.S. CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 55. U.S. CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 56. U.S. CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CANADA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 58. CANADA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 59. CANADA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 60. CANADA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEXICO CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 62. MEXICO CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 63. MEXICO CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. MEXICO CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 66. EUROPE MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. EUROPE EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 68. EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 69. EUROPE NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 71. EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. EUROPE CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 73. GERMANY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 74. GERMANY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 75. GERMANY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. GERMANY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. FRANCE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 78. FRANCE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 79. FRANCE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. FRANCE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. UK CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 82. UK CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 83. UK CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. UK CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. ITALY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 86. ITALY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 87. ITALY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 88. ITALY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. SPAIN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 90. SPAIN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 91. SPAIN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. SPAIN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 94. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 95. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 96. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 100. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 101. ASIA-PACIFIC NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 102. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 103. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 105. JAPAN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 106. JAPAN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 107. JAPAN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 108. JAPAN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. CHINA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 110. CHINA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 111. CHINA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 112. CHINA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 114. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 115. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 116. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. INDIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 118. INDIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 119. INDIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 120. INDIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 122. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 123. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 124. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 125. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 126. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 127. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 128. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 129. LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 130. LAMEA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 131. LAMEA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 132. LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 133. LAMEA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 134. LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 135. LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 136. LAMEA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 137. BRAZIL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 138. BRAZIL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 139. BRAZIL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 140. BRAZIL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 141. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 142. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 143. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 144. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 145. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 146. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 147. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 148. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 149. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 150. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 151. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 152. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 153.ADVANCED INSTRUMENTS LLC: COMPANY SNAPSHOT
TABLE 154.ADVANCED INSTRUMENTS LLC: OPERATING SEGMENTS
TABLE 155.ADVANCED INSTRUMENTS LLC: PRODUCT PORTFOLIO
TABLE 156.ADVANCED INSTRUMENTS LLC: NET SALES,
TABLE 157.ADVANCED INSTRUMENTS LLC: KEY STRATERGIES
TABLE 158.AGC BIOLOGICS: COMPANY SNAPSHOT
TABLE 159.AGC BIOLOGICS: OPERATING SEGMENTS
TABLE 160.AGC BIOLOGICS: PRODUCT PORTFOLIO
TABLE 161.AGC BIOLOGICS: NET SALES,
TABLE 162.AGC BIOLOGICS: KEY STRATERGIES
TABLE 163.CYTIVA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 164.CYTIVA LIFESCIENCES: OPERATING SEGMENTS
TABLE 165.CYTIVA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 166.CYTIVA LIFESCIENCES: NET SALES,
TABLE 167.CYTIVA LIFESCIENCES: KEY STRATERGIES
TABLE 168.SARTORIUS: COMPANY SNAPSHOT
TABLE 169.SARTORIUS: OPERATING SEGMENTS
TABLE 170.SARTORIUS: PRODUCT PORTFOLIO
TABLE 171.SARTORIUS: NET SALES,
TABLE 172.SARTORIUS: KEY STRATERGIES
TABLE 173.CELLGENIX GMBH: COMPANY SNAPSHOT
TABLE 174.CELLGENIX GMBH: OPERATING SEGMENTS
TABLE 175.CELLGENIX GMBH: PRODUCT PORTFOLIO
TABLE 176.CELLGENIX GMBH: NET SALES,
TABLE 177.CELLGENIX GMBH: KEY STRATERGIES
TABLE 178.PREMAS BIOTECH: COMPANY SNAPSHOT
TABLE 179.PREMAS BIOTECH: OPERATING SEGMENTS
TABLE 180.PREMAS BIOTECH: PRODUCT PORTFOLIO
TABLE 181.PREMAS BIOTECH: NET SALES,
TABLE 182.PREMAS BIOTECH: KEY STRATERGIES
TABLE 183.SELEXIS SA: COMPANY SNAPSHOT
TABLE 184.SELEXIS SA: OPERATING SEGMENTS
TABLE 185.SELEXIS SA: PRODUCT PORTFOLIO
TABLE 186.SELEXIS SA: NET SALES,
TABLE 187.SELEXIS SA: KEY STRATERGIES
TABLE 188.SAMSUNG BIOLOGICS: COMPANY SNAPSHOT
TABLE 189.SAMSUNG BIOLOGICS: OPERATING SEGMENTS
TABLE 190.SAMSUNG BIOLOGICS: PRODUCT PORTFOLIO
TABLE 191.SAMSUNG BIOLOGICS: NET SALES,
TABLE 192.SAMSUNG BIOLOGICS: KEY STRATERGIES
TABLE 193.LONZA: COMPANY SNAPSHOT
TABLE 194.LONZA: OPERATING SEGMENTS
TABLE 195.LONZA: PRODUCT PORTFOLIO
TABLE 196.LONZA: NET SALES,
TABLE 197.LONZA: KEY STRATERGIES
TABLE 198.THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 199.THERMOFISHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 200.THERMOFISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 201.THERMOFISHER SCIENTIFIC INC: NET SALES,
TABLE 202.THERMOFISHER SCIENTIFIC INC: KEY STRATERGIES
TABLE 203.PROMOCELL: COMPANY SNAPSHOT
TABLE 204.PROMOCELL: OPERATING SEGMENTS
TABLE 205.PROMOCELL: PRODUCT PORTFOLIO
TABLE 206.PROMOCELL: NET SALES,
TABLE 207.PROMOCELL: KEY STRATERGIES
TABLE 208.PROBIOGEN: COMPANY SNAPSHOT
TABLE 209.PROBIOGEN: OPERATING SEGMENTS
TABLE 210.PROBIOGEN: PRODUCT PORTFOLIO
TABLE 211.PROBIOGEN: NET SALES,
TABLE 212.PROBIOGEN: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.CELL LINE AND MEMBRANE MARKET SEGMENTATION
FIGURE 2.CELL LINE AND MEMBRANE MARKET,2021-2031
FIGURE 3.CELL LINE AND MEMBRANE MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CELL LINE AND MEMBRANE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.CELL LINE AND MEMBRANE MARKET,BY PRODUCTS,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EQUIPMENTS CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES AND CONSUMABLES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 16.CELL LINE AND MEMBRANE MARKET,BY SOURCE,2021(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 19.CELL LINE AND MEMBRANE MARKET,BY TYPE,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF RECOMBINANT CELL LINES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PRIMARY CELL LINES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HYBRIDOMAS CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CONTINUOUS CELL LINES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 24.CELL LINE AND MEMBRANE MARKET,BY END USER,2021(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH INSTITUTES CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS CELL LINE AND MEMBRANE MARKET,2021-2031(%)
FIGURE 28.CELL LINE AND MEMBRANE MARKET BY REGION,2021
FIGURE 29.U.S. CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 30.CANADA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 31.MEXICO CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 32.GERMANY CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 33.FRANCE CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 34.UK CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 35.ITALY CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 36.SPAIN CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 37.REST OF EUROPE CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 38.JAPAN CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 39.CHINA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 40.AUSTRALIA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 41.INDIA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 42.SOUTH KOREA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 43.REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 44.BRAZIL CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 45.SAUDI ARABIA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 46.SOUTH AFRICA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 47.REST OF LAMEA CELL LINE AND MEMBRANE MARKET,2021-2031($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE DASHBOARD
FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54.ADVANCED INSTRUMENTS LLC.: NET SALES ,($MILLION)
FIGURE 55.AGC BIOLOGICS.: NET SALES ,($MILLION)
FIGURE 56.CYTIVA LIFESCIENCES.: NET SALES ,($MILLION)
FIGURE 57.SARTORIUS.: NET SALES ,($MILLION)
FIGURE 58.CELLGENIX GMBH.: NET SALES ,($MILLION)
FIGURE 59.PREMAS BIOTECH.: NET SALES ,($MILLION)
FIGURE 60.SELEXIS SA.: NET SALES ,($MILLION)
FIGURE 61.SAMSUNG BIOLOGICS.: NET SALES ,($MILLION)
FIGURE 62.LONZA.: NET SALES ,($MILLION)
FIGURE 63.THERMOFISHER SCIENTIFIC INC.: NET SALES ,($MILLION)
FIGURE 64.PROMOCELL.: NET SALES ,($MILLION)
FIGURE 65.PROBIOGEN.: NET SALES ,($MILLION)

Product Code: A13858

The global cell line and membrane market was valued at $4,533.04 million in 2021, and is projected to reach $10,574.56 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.A cell line is a permanently established cell culture that will multiply indefinitely in a given appropriate fresh medium and space and is frequently used to investigate biological processes in place of primary cells. Transfection, selection, and single-cell cloning are all a part of the cell line generation process. Various types of cells are used to create different cell lines. Cell lines allow for the gradual changes in cell structure, physiology, and genetic makeup in a controlled setting. . Cell lines are derived from single cells and are used to make fusion proteins, monoclonal antibodies, and vaccines.

Cell lines have revolutionized scientific research and they are widely used in the production of vaccine, testing drug metabolism & cytotoxicity, antibody production, study of gene function, generation of artificial tissues (artificial skin), and synthesis of biological compounds (therapeutic proteins).

The key factors that drive the growth of market are rise in the prevalence of cancer & chronic diseases, rise in geriatric population, and increase in number of vaccine production. In addition, the rise in novel drug development activities, growth in use of mammalian cell for cell line production, and surge in technological advancements in expression vector design are the key factors that boost the market growth. For instance, according to the International Agency of Cancer Research, 9,503,710 new cancer cases were diagnosed in Asia in 2020.

However, the strict regulatory framework coupled with the time-consuming process for the development of stable lines hampers the market growth. Conversely, emerging healthcare market in developing countries & low-income countries and increase in the risk of pandemic & communicable diseases are expected to provide lucrative opportunity for the growth of market during the forecast period.

The cell line and membrane market is segmented on the basis of product, source, type, end user, and region. By product, the market is fragmented into media & reagents, equipment, accessories, and consumables. By source, it is bifurcated into mammalian cell line and non-mammalian cell line. On the basis of type, the market is categorized into recombinant cell type, hybridomas, continuous cell line and primary cell line. By end user, the market is divided into biotech companies, academic and research institutes and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and presence of major key players in the region.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population in developing countries.

The key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell line and membrane market analysis from 2021 to 2031 to identify the prevailing cell line and membrane market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cell line and membrane market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell line and membrane market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Products

Media and Reagents
- Type
- Serum
- Media
- Reagents
Equipments
- Type
- Biosafety Cabinets
- Cell Counters and Viability Systems
- Incubators
- Centrifuges
- Bioreactors
- Storage Equipment
- Others
Accessories and Consumables

By Source

Non Mammalian Cell Line
- Type
- Insects
- Amphibians
Mammalian Cell Line

By Type

Hybridomas
Continuous cell lines
Recombinant cell lines
Primary cell lines

By End User

Biotechnology and Pharmaceutical Industries
Academic and Research Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Advanced Instruments LLC
- AGC Biologics
- Cytiva Lifesciences
- Sartorius
- Cellgenix Gmbh
- Premas Biotech
- Selexis SA
- Samsung Biologics
- Lonza
- Thermofisher Scientific Inc
- PromoCell
- ProBioGen

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Media and Reagents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Media and Reagents Cell Line and Membrane Market by Type
  - 4.2.4.1 Serum Market size and forecast, by region
  - 4.2.4.2 Media Market size and forecast, by region
  - 4.2.4.3 Reagents Market size and forecast, by region
4.3 Equipments
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Equipments Cell Line and Membrane Market by Type
  - 4.3.4.1 Biosafety Cabinets Market size and forecast, by region
  - 4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
  - 4.3.4.3 Incubators Market size and forecast, by region
  - 4.3.4.4 Centrifuges Market size and forecast, by region
  - 4.3.4.5 Bioreactors Market size and forecast, by region
  - 4.3.4.6 Storage Equipment Market size and forecast, by region
  - 4.3.4.7 Others Market size and forecast, by region
4.4 Accessories and Consumables
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country

CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Non Mammalian Cell Line
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
  - 5.2.4.1 Insects Market size and forecast, by region
  - 5.2.4.2 Amphibians Market size and forecast, by region
5.3 Mammalian Cell Line
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country

CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Recombinant cell lines
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Primary cell lines
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Hybridomas
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Continuous cell lines
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country

CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Biotechnology and Pharmaceutical Industries
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Academic and Research Institutes
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Others
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country

CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Products
  - 8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
  - 8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
- 8.2.3 North America Market size and forecast, by Source
  - 8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.2.4 North America Market size and forecast, by Type
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Products
  - 8.2.6.1.2 Market size and forecast, by Source
  - 8.2.6.1.3 Market size and forecast, by Type
  - 8.2.6.1.4 Market size and forecast, by End User
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Products
  - 8.2.6.2.2 Market size and forecast, by Source
  - 8.2.6.2.3 Market size and forecast, by Type
  - 8.2.6.2.4 Market size and forecast, by End User
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Products
  - 8.2.6.3.2 Market size and forecast, by Source
  - 8.2.6.3.3 Market size and forecast, by Type
  - 8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Products
  - 8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
  - 8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
- 8.3.3 Europe Market size and forecast, by Source
  - 8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.3.4 Europe Market size and forecast, by Type
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 Germany
  - 8.3.6.1.1 Market size and forecast, by Products
  - 8.3.6.1.2 Market size and forecast, by Source
  - 8.3.6.1.3 Market size and forecast, by Type
  - 8.3.6.1.4 Market size and forecast, by End User
  - 8.3.6.2 France
  - 8.3.6.2.1 Market size and forecast, by Products
  - 8.3.6.2.2 Market size and forecast, by Source
  - 8.3.6.2.3 Market size and forecast, by Type
  - 8.3.6.2.4 Market size and forecast, by End User
  - 8.3.6.3 UK
  - 8.3.6.3.1 Market size and forecast, by Products
  - 8.3.6.3.2 Market size and forecast, by Source
  - 8.3.6.3.3 Market size and forecast, by Type
  - 8.3.6.3.4 Market size and forecast, by End User
  - 8.3.6.4 Italy
  - 8.3.6.4.1 Market size and forecast, by Products
  - 8.3.6.4.2 Market size and forecast, by Source
  - 8.3.6.4.3 Market size and forecast, by Type
  - 8.3.6.4.4 Market size and forecast, by End User
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Products
  - 8.3.6.5.2 Market size and forecast, by Source
  - 8.3.6.5.3 Market size and forecast, by Type
  - 8.3.6.5.4 Market size and forecast, by End User
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Products
  - 8.3.6.6.2 Market size and forecast, by Source
  - 8.3.6.6.3 Market size and forecast, by Type
  - 8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Products
  - 8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
  - 8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
- 8.4.3 Asia-Pacific Market size and forecast, by Source
  - 8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.4.4 Asia-Pacific Market size and forecast, by Type
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Products
  - 8.4.6.1.2 Market size and forecast, by Source
  - 8.4.6.1.3 Market size and forecast, by Type
  - 8.4.6.1.4 Market size and forecast, by End User
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Products
  - 8.4.6.2.2 Market size and forecast, by Source
  - 8.4.6.2.3 Market size and forecast, by Type
  - 8.4.6.2.4 Market size and forecast, by End User
  - 8.4.6.3 Australia
  - 8.4.6.3.1 Market size and forecast, by Products
  - 8.4.6.3.2 Market size and forecast, by Source
  - 8.4.6.3.3 Market size and forecast, by Type
  - 8.4.6.3.4 Market size and forecast, by End User
  - 8.4.6.4 India
  - 8.4.6.4.1 Market size and forecast, by Products
  - 8.4.6.4.2 Market size and forecast, by Source
  - 8.4.6.4.3 Market size and forecast, by Type
  - 8.4.6.4.4 Market size and forecast, by End User
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Products
  - 8.4.6.5.2 Market size and forecast, by Source
  - 8.4.6.5.3 Market size and forecast, by Type
  - 8.4.6.5.4 Market size and forecast, by End User
  - 8.4.6.6 Rest of Asia-Pacific
  - 8.4.6.6.1 Market size and forecast, by Products
  - 8.4.6.6.2 Market size and forecast, by Source
  - 8.4.6.6.3 Market size and forecast, by Type
  - 8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Products
  - 8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
  - 8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
- 8.5.3 LAMEA Market size and forecast, by Source
  - 8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.5.4 LAMEA Market size and forecast, by Type
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Products
  - 8.5.6.1.2 Market size and forecast, by Source
  - 8.5.6.1.3 Market size and forecast, by Type
  - 8.5.6.1.4 Market size and forecast, by End User
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Products
  - 8.5.6.2.2 Market size and forecast, by Source
  - 8.5.6.2.3 Market size and forecast, by Type
  - 8.5.6.2.4 Market size and forecast, by End User
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Products
  - 8.5.6.3.2 Market size and forecast, by Source
  - 8.5.6.3.3 Market size and forecast, by Type
  - 8.5.6.3.4 Market size and forecast, by End User
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Products
  - 8.5.6.4.2 Market size and forecast, by Source
  - 8.5.6.4.3 Market size and forecast, by Type
  - 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 Advanced Instruments LLC
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 AGC Biologics
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 Cytiva Lifesciences
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 Sartorius
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 Cellgenix Gmbh
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Premas Biotech
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 Selexis SA
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 Samsung Biologics
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 Lonza
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 Thermofisher Scientific Inc
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
10.11 PromoCell
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
10.12 ProBioGen
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments

細胞株・膜の市場：製品別、供給元別、タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cell Line and Membrane Market By Products, By Source, By Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章細胞株・膜市場：製品別

第5章細胞株・膜市場：供給元別

第6章細胞株・膜市場：タイプ別

第7章細胞株・膜市場：エンドユーザー別

第8章細胞株・膜市場：地域別

第9章企業情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS

CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE

CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE

CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER

CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

細胞株・膜の市場：製品別、供給元別、タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cell Line and Membrane Market By Products, By Source, By Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 細胞株・膜市場：製品別

第5章 細胞株・膜市場：供給元別

第6章 細胞株・膜市場：タイプ別

第7章 細胞株・膜市場： エンドユーザー別

第8章 細胞株・膜市場：地域別

第9章 企業情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS

CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE

CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE

CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER

CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章細胞株・膜市場：製品別

第5章細胞株・膜市場：供給元別

第6章細胞株・膜市場：タイプ別

第7章細胞株・膜市場：エンドユーザー別

第8章細胞株・膜市場：地域別

第9章企業情勢

第10章企業プロファイル